German Court Recognizes Saphenus Sensory Feedback System Reimbursable by Statutory Health Insurance

BADEN BEI WIEN, Austria - Nov. 11, 2025 - PRLog -- After a prolonged legal process, a patient has prevailed in a groundbreaking case before the Social Court of Chemnitz. The court ruled that the sensory feedback system developed by Saphenus Medical Technology qualifies as a medical aid for mobility compensation, making it eligible for reimbursement by statutory health insurance in Germany.

In its judgment (not yet final), the court held that the technology constitutes a mobility aid, and therefore does not require a positive assessment by the Federal Joint Committee (G-BA), which is typically necessary for therapeutic devices. The judges based their reasoning on recent rulings by the Federal Social Court (BSG) concerning improvements in everyday mobility and participation for people with disabilities.

"According to the manufacturer's product description, the device serves to improve mobility by enhancing gait stability through sensory feedback — particularly when visual control is limited, such as when stepping backwards or sideways. The ability to move quickly and safely in all directions without prior preparation is crucial for independent mobility and social participation. Systems such as this, which serve to compensate for a disability, are not subject to the method reservation (Methodenvorbehalt) under the recent case law of the Federal Social Court (BSG, Judgment of April 18, 2024 – B 3 KR 13/22 R, paras. 19 f). Social Court Chemnitz, Decision of April 7, 2025 – Case No. S 18 KR 340/24 (not final)

This decision marks a milestone for amputees seeking access to advanced neuroprosthetic technologies that restore sensory feedback and natural movement. It acknowledges that modern assistive technologies like the Saphenus Suralis system play a vital role in **restoring everyday mobility, stability, and independence.

---

About Saphenus Medical Technology

Saphenus Medical Technology is a global pioneer in neuroprosthetics. With its **FDA- and MDR-cleared medical devices, including Suralis and Hyperion, the company develops innovative solutions to eliminate phantom limb pain and enhance gait stability through the restoration of the natural sense of touch.
Saphenus collaborates with Harvard Medical School, Hannover Medical School (MHH), and other leading institutions worldwide to advance clinical research in sensory neuroprosthetics.

http://www.saphenus.com
http://www.phantompainfree.com